BioRestorative Therapies Financial Overview
BioRestorative Therapies's market cap is currently $11.81M. The company's EPS TTM is $-0.33; its P/E ratio is ―; BioRestorative Therapies is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
